Vasou, A., Nightingale, K., Cetkovská, V., Scheler, J., Bamford, C. G. G., Andrejeva, J., Rowe, J. C., Swatek, K. N., Schwarz‐Linek, U., Randall, R. E., McLauchlan, J., Weekes, M. P., Bogunovic, D., & Hughes, D. J. (2025). ISG15‐Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans. European Journal of Immunology, 55(2). Portico. https://doi.org/10.1002/eji.202451651

Mougari, S., Favède, V., Predella, C., Reynard, O., Durand, S., Mazelier, M., Pizzioli, E., Decimo, D., Bovier, F. T., Lapsley, L. M., Castagna, C., Lieberman, N. A. P., Noel, G., Mathieu, C., Malissen, B., Briese, T., Greninger, A. L., Alabi, C. A., Dorrello, N. V., … Horvat, B. (2025). Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity. Communications Biology, 8(1). https://doi.org/10.1038/s42003-025-07491-4

Xie, S. C., Tai, C.-W., Morton, C. J., Ma, L., Huang, S.-C., Wittlin, S., Du, Y., Hu, Y., Dogovski, C., Salimimarand, M., Griffin, R., England, D., de la Cruz, E., Deni, I., Yeo, T., Burkhard, A. Y., Striepen, J., Schindler, K. A., Crespo, B., … Tilley, L. (2024). A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo. PLOS Pathogens, 20(12), e1012429. https://doi.org/10.1371/journal.ppat.1012429

Yalcouyé, A., Schrauwen, I., Traoré, O., Bamba, S., Aboagye, E. T., Acharya, A., Bharadwaj, T., Latanich, R., Esoh, K., Fortes-Lima, C. A., de Kock, C., Jonas, M., Maiga, A. dit B., Cissé, C. A. K., Sangaré, M. A., Guinto, C. O., Landouré, G., Leal, S. M., & Wonkam, A. (2025). Whole-exome sequencing reveals known and candidate genes for hearing impairment in Mali. Human Genetics and Genomics Advances, 6(1), 100391. https://doi.org/10.1016/j.xhgg.2024.100391

Shin, H., & Chung, H. (2023). SMPDL3A links cholesterol metabolism to the cGAS-STING pathway. Immunity, 56(11), 2459–2461. https://doi.org/10.1016/j.immuni.2023.10.015

Mihreteab, S., Platon, L., Berhane, A., Stokes, B. H., Warsame, M., Campagne, P., Criscuolo, A., Ma, L., Petiot, N., Doderer-Lang, C., Legrand, E., Ward, K. E., Zehaie Kassahun, A., Ringwald, P., Fidock, D. A., & Ménard, D. (2023). Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. New England Journal of Medicine, 389(13), 1191–1202. https://doi.org/10.1056/nejmoa2210956

Hagan, T., Gerritsen, B., Tomalin, L. E., Fourati, S., Mulè, M. P., Chawla, D. G., Rychkov, D., Henrich, E., Miller, H. E. R., Diray-Arce, J., Dunn, P., Lee, A., Deckhut-Augustine, A., Gottardo, R., Haddad, E. K., Hafler, D. A., Harris, E., Farber, D., … Pulendran, B. (2022). Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses. Nature Immunology, 23(12), 1788–1798. https://doi.org/10.1038/s41590-022-01328-6

Yang, M., Fan, Q., Hei, T. K., Chen, G., Cao, W., Meng, G., & Han, W. (2022). Single-Cell Transcriptome Analysis of Radiation Pneumonitis Mice. Antioxidants, 11(8), 1457. https://doi.org/10.3390/antiox11081457

Sahajpal, N. S., Jill Lai, C.-Y., Hastie, A., Mondal, A. K., Dehkordi, S. R., van der Made, C. I., Fedrigo, O., Al-Ajli, F., Jalnapurkar, S., Byrska-Bishop, M., Kanagal-Shamanna, R., Levy, B., Schieck, M., Illig, T., Bacanu, S.-A., Chou, J. S., Randolph, A. G., Rojiani, A. M., Zody, M. C., … Kolhe, R. (2022). Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. IScience, 25(2), 103760. https://doi.org/10.1016/j.isci.2022.103760

Meric-Bernstam, F., Sweis, R. F., Hodi, F. S., Messersmith, W. A., Andtbacka, R. H. I., Ingham, M., Lewis, N., Chen, X., Pelletier, M., Chen, X., Wu, J., Dubensky, T. W., McWhirter, S. M., Müller, T., Nair, N., & Luke, J. J. (2021). Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas. Clinical Cancer Research, 28(4), 677–688. https://doi.org/10.1158/1078-0432.ccr-21-1963

Yalcinkaya, M., Liu, W., Islam, M. N., Kotini, A. G., Gusarova, G. A., Fidler, T. P., Papapetrou, E. P., Bhattacharya, J., Wang, N., & Tall, A. R. (2021). Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-04133-7

Reichmann, M., Tezera, L., Vallejo, A., Vukmirovic, M., Xiao, R., Jogai, S., Wilson, S., Marshall, B., Jones, M., Leslie, A., D’Armiento, J., Kaminski, N., Polak, M., & Elkington, P. (2021). T3 Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies sphingosine kinase 1 as a potential therapeutic target. BTS/BALR/AUK-BLF Early Career Investigator Symposium, A2–A3. https://doi.org/10.1136/thorax-2021-btsabstracts.3

Ager, C. R., Boda, A., Rajapakshe, K., Lea, S. T., Di Francesco, M. E., Jayaprakash, P., Slay, R. B., Morrow, B., Prasad, R., Dean, M. A., Duffy, C. R., Coarfa, C., Jones, P., & Curran, M. A. (2021). High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Journal for ImmunoTherapy of Cancer, 9(8), e003246. https://doi.org/10.1136/jitc-2021-003246